In this study, we applied a genome-first approach to interrogate the exome sequence of individuals in three large population and health system-based cohorts to quantify germline P/LP variant prevalence and examined cancer prevalence and survival of adults with non-NF1 RAS/MAPK P/LP variants. Here, NF1 is linked to cancer.